Ablation of type-1 IFN signaling in hematopoietic cells confers protection following traumatic brain injury

IP Karve; M Zhang; M Habgood; T Frugier; KM Brody; M Sashindranath; C Joakim Ek; S Chappaz; BT Kile; D Wright; H Wang; L Johnston; M Daglas; RC Ates; RL Medcalf; JM Taylor; PJ Crack

Journal article

Ablation of type-1 IFN signaling in hematopoietic cells confers protection following traumatic brain injury

IP Karve, M Zhang, M Habgood, T Frugier, KM Brody, M Sashindranath, C Joakim Ek, S Chappaz, BT Kile, D Wright, H Wang, L Johnston, M Daglas, RC Ates, RL Medcalf, JM Taylor, PJ Crack

Eneuro | SOC NEUROSCIENCE | Published : 2016

DOI: 10.1523/ENEURO.0128-15.2016

Download PDF

Abstract

Type-1 interferons (IFNs) are pleiotropic cytokines that signal through the type-1 IFN receptor (IFNAR1). Recent literature has implicated the type-1 IFNs in disorders of the CNS. In this study, we have investigated the role of type-1 IFNs in neuroinflammation following traumatic brain injury (TBI). Using a controlled cortical impact model, TBI was induced in 8- to 10-week-old male C57BL/6J WT and IFNAR1-/-mice and brains were excised to study infarct volume, inflammatory mediator release via quantitative PCR analysis and immune cell profile via immunohistochemistry. IFNAR1-/-mice displayed smaller infarcts compared with WT mice after TBI. IFNAR1-/-mice exhibited an altered anti-inflammatory..

View full abstract

University of Melbourne Researchers

Kate Brody Author

Leigh Johnston Author

Maria Daglas Author

Peter Crack Author

Related Projects (2)

Interferon and neural injury

This project focuses on the role that inflammation plays in the progression of the type of neural injury seen in stroke victims. This projec..

Controlling neuroinflammation in Alzheimers Disease

Alzheimer’s disease (AD) is the most common neurodegenerative disorder worldwide, with 269,000 Australians currently diagnosed with AD and i..

Grants

Awarded by National Science Foundation

Funding Acknowledgements

This work was supported by National Health and Medical Research Council of Australia Project Grant 628391 (PJC) and Project Grant 1044714 (PJC, JMT), an Australian Research Council Future Fellowship (PJC) and the Rebecca Cooper Foundation.